An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.
3
Funding Rounds
$143.4m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Pe* Lu**** | - | - | - |
Name | Phone | Social networks | |
---|---|---|---|
Pa** Ca**** (e************ | - | - | - |
Vi** Sh*********** | - | - | |
Ke*** Ra*** | - | - | - |
Sa*** Go**** Wi** | - | - | - |
Ma**** An***** | - | - | - |
Am*** Na**** | - | - | - |
Jo** Mc********* | - | - | - |
Ev** Ca**** | - | - | - |
An***** de Fo********* | - | - |
The company Evox Therapeutics has raised a total of $95.98m in funding over 3 rounds.